4.74
+0.07(+1.50%)
Currency In USD
Previous Close | 4.67 |
Open | 4.66 |
Day High | 4.75 |
Day Low | 4.64 |
52-Week High | 7.63 |
52-Week Low | 4.11 |
Volume | 970,849 |
Average Volume | 2.03M |
Market Cap | 1.44B |
PE | 47.4 |
EPS | 0.1 |
Moving Average 50 Days | 5.06 |
Moving Average 200 Days | 5.93 |
Change | 0.07 |
If you invested $1000 in MannKind Corporation (MNKD) 10 years ago, it would be worth $206.54 as of April 27, 2025 at a share price of $4.74. Whereas If you bought $1000 worth of MannKind Corporation (MNKD) shares 5 years ago, it would be worth $3,434.78 as of April 27, 2025 at a share price of $4.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
GlobeNewswire Inc.
Apr 07, 2025 4:30 PM GMT
No. 76 MannKind "Tired of Pricks? Livery Junco Hollinger Racing driver Conor Daly to power the No. 76 MannKind "Tired of Pricks?" Chevrolet at the 2025 Acura Grand Prix of Long Beach to raise awareness of diabetes and innovative treatment options
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
GlobeNewswire Inc.
Mar 10, 2025 10:05 AM GMT
Five presentations affirm positive outcomes utilizing inhaled insulinAn sNDA filing for Afrezza in pediatric population anticipated in 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
GlobeNewswire Inc.
Feb 19, 2025 9:05 PM GMT
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), will release its 2024 fourth quarter and full year financial results after market close on Wednesday, February 26, 2025. MannKind wi